Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

5.025 +0.035 (+0.70%)

Streaming Delayed Price Updated: 11:12 AM EDT, Apr 22, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	127,590
Open	4.990
Bid (Size)	5.020 (600)
Ask (Size)	5.030 (900)
Prev. Close	4.990
Today's Range	4.985 - 5.080
52wk Range	3.760 - 8.590
Shares Outstanding	93,500,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026

April 16, 2026

From Myriad Genetics, Inc.

Via GlobeNewswire

Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan

April 14, 2026

From Myriad Genetics, Inc.

Via GlobeNewswire

Performance

YTD	-18.2%	-18.2%
1 Month	+7.8%	+7.8%
3 Month	-11.5%	-11.5%
6 Month	-37.7%	-37.7%
1 Year	-32.1%	-32.1%

More News

1 Cash-Burning Stock to Target This Week and 2 We Question

April 13, 2026

Via StockStory

Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting

April 09, 2026

From Myriad Genetics, Inc.

Via GlobeNewswire

Myriad Genetics Inc (NASDAQ:MYGN) Stock Surges 19.6% on Strong Q4 Earnings Beat ↗

February 23, 2026

Via Chartmill

Q4 Earnings Highlights: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

April 05, 2026

Via StockStory

3 Healthcare Stocks with Open Questions

April 02, 2026

Via StockStory

Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

March 27, 2026

Via StockStory

Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer

March 17, 2026

From Myriad Genetics, Inc.

Via GlobeNewswire

2 High-Flying Stocks with Competitive Advantages and 1 We Brush Off

March 17, 2026

Via StockStory

Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc

March 11, 2026

Via StockStory

3 Reasons to Sell MYGN and 1 Stock to Buy Instead

March 11, 2026

Via StockStory

Myriad Genetics (MYGN) Shares Skyrocket, What You Need To Know

March 10, 2026

Via StockStory

3 Stocks Under $10 We Keep Off Our Radar

March 10, 2026

Via StockStory

2 Unprofitable Stocks on Our Buy List and 1 We Brush Off

March 05, 2026

Via StockStory

Myriad Genetics (MYGN) Stock Trades Up, Here Is Why

March 03, 2026

Via StockStory

Myriad Commercially Launches Precise MRD with Select Community Oncologists

March 02, 2026

From Myriad Genetics, Inc.

Via GlobeNewswire

PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know

February 27, 2026

Via StockStory

Why Myriad Genetics (MYGN) Stock Is Trading Up Today

February 24, 2026

Via StockStory

Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests

February 24, 2026

From Myriad Genetics, Inc.

Via GlobeNewswire

Myriad Genetics (MYGN) Q4 2025 Earnings Transcript ↗

February 23, 2026

Via The Motley Fool

What's going on in today's after hours session ↗

February 23, 2026

Via Chartmill

Myriad Genetics’s (NASDAQ:MYGN) Q4 CY2025 Sales Top Estimates, Stock Jumps 22%

February 23, 2026

Via StockStory

Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution

February 23, 2026

From Myriad Genetics, Inc.

Via GlobeNewswire

iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know

February 23, 2026

Via StockStory

Frequently Asked Questions

Is Myriad Genetics, Inc. - Common Stock publicly traded?

Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.

What exchange does Myriad Genetics, Inc. - Common Stock trade on?

Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?

The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market

What is the current price of Myriad Genetics, Inc. - Common Stock?

The current price of Myriad Genetics, Inc. - Common Stock is 5.025

When was Myriad Genetics, Inc. - Common Stock last traded?

The last trade of Myriad Genetics, Inc. - Common Stock was at 04/22/26 11:12 AM ET

What is the market capitalization of Myriad Genetics, Inc. - Common Stock?

The market capitalization of Myriad Genetics, Inc. - Common Stock is 469.84M

How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?

Myriad Genetics, Inc. - Common Stock has 470M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.